{"result": "(\"entity\"<|>IT ORAL<|>EVENT<|>IT oral is a treatment method that induces immune tolerance through the oral administration of allergens, primarily targeting intestinal mechanisms.)\n##\n(\"entity\"<|>IT NASAL<|>EVENT<|>IT nasal is a treatment method that induces immune tolerance through nasal administration of allergens, primarily targeting bronchial mechanisms.)\n##\n(\"entity\"<|>ALERGIAS ALIMENTARIAS<|>EVENT<|>Food allergies are adverse immune responses to certain food proteins, which can lead to severe reactions in sensitive individuals.)\n##\n(\"entity\"<|>REGLAMENTO (UE) N.º 1169/2011<|>ORGANIZATION<|>The EU Regulation No. 1169/2011 governs food information provided to consumers, including allergen labeling requirements.)\n##\n(\"entity\"<|>AEPNAA<|>ORGANIZATION<|>The AEPNAA is an association that provides resources and updates on food allergies and intolerances, helping patients manage their conditions.)\n##\n(\"entity\"<|>ALERGIAS INFANTILES<|>EVENT<|>Childhood allergies refer to allergic reactions occurring in children, often requiring specific management and treatment strategies.)\n##\n(\"relationship\"<|>IT ORAL<|>ALERGIAS ALIMENTARIAS<|>IT oral is a treatment method aimed at managing food allergies by inducing tolerance through oral allergen exposure.<|>7)\n##\n(\"relationship\"<|>IT NASAL<|>ALERGIAS ALIMENTARIAS<|>IT nasal is a treatment method aimed at managing food allergies by inducing tolerance through nasal allergen exposure.<|>7)\n##\n(\"relationship\"<|>REGLAMENTO (UE) N.º 1169/2011<|>ALERGIAS ALIMENTARIAS<|>The EU Regulation No. 1169/2011 establishes labeling requirements for allergens in food products, directly impacting food allergies management.<|>8)\n##\n(\"relationship\"<|>AEPNAA<|>ALERGIAS ALIMENTARIAS<|>The AEPNAA provides resources and support for individuals with food allergies, helping them navigate their dietary restrictions.<|>6)\n##\n(\"relationship\"<|>AEPNAA<|>ALERGIAS INFANTILES<|>The AEPNAA also focuses on childhood allergies, providing information and support for managing allergies in children.<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: operan sobre los sistemas inmunes de mucosas (SIM) inducen algunos de los mecanismos que median la tolerancia inmunológica. De esta manera, la IT basada en la administración oral del alérgeno, denominada IT oral, permite instaurar mecanismos de tolerancia a nivel intestinal; la IT nasal permite instaurar mecanismos de tolerancia a nivel bronquial, capaces de controlar el SIM intestinal. Sin embargo, no se conocen completamente los mecanismos que gobiernan estos tratamientos, y esto ha generado en los últimos años un marcado interés en su estudio en todo el mundo, principalmente en asma y alergia alimentaria. A pesar de los avances logrados en los últimos tiempos en el desarrollo de las IT, los principales obstáculos de las mismas, y especialmente en pacientes con alergia alimentaria, continúan siendo las reacciones adversas que se producen al exponer el es paciente sensibilizado al alergeno nocivo. En todos los ensayos clínicos realizados se observa la aparición de al menos un 10% de pacientes que deben abandonar el tratamiento por la aparición de reacciones adversas. Este escollo ha determinado que, para las alergias alimentarias, no exista hasta el momento un protocolo estandarizado y aprobado para aplicar en pacientes con alergia IgE-mediada. El desarrollo más reciente ha sido la IT sublingual, que permitió reducir las reacciones tóxicas por la menor dosis de alergeno que se emplea en la administración sublingual, en comparación con el tratamiento oral. En este último, el transporte del alergeno por el estómago y el intestino significan su degradación parcial hasta alcanzar la mucosa del intestino delgado, duodeno principalmente, donde es absorbido37, 38. En cambio, en la IT sublingual el alergeno es absorbido en la mucosa bucal en su forma nativa, y como tal es captado por las células dendríticas subyacentes para luego activar los LT específicos. Sin embargo, a pesar de disminuir los signos clínicos postadministración del alergeno, distintos trabajos han demostrado que los protocolos actuales muestran una eficiencia menor en la inducción de T-reguladores (Treg) con respecto a la IT oral39. Es decir, que actualmente se están estudiando distintos procedimientos terapéuticos correctivos para las alergias alimentarias, los que han logrado inducir dos tipos de mecanismos para controlar las reacciones alérgicas mediadas por IgE: desensibilización y tolerancia.\n\nSe hace necesario disponer de información que pueda permitir conocer el umbral del alergeno que desata la aparición de la reacción alérgica para que, a continua-\n---\nTema 42. Alergias e intolerancias alimentarias. Diagnóstico y tratamiento 689\n\nción, mediante unas rigurosas normas en el etiquetado, los usuarios puedan disponer de información segura a la hora de adquirir los alimentos. El actual etiquetado se rige por el Reglamento (UE) N.º 1169/2011 del Parlamento Europeo y del Consejo del 25 de octubre de 2011 sobre información alimentaria facilitada al consumidor, que se aplica desde el 13 de diciembre de 2014, excepto las indicaciones relativas a la información nutricional, que son aplicables a partir del 13 de diciembre de 2016. A pesar de que los consumidores pueden presentar sensibilidad a otros productos, la normativa solo exige destacar 14 alérgenos en la lista de ingredientes de la etiqueta. Por primera vez se hace extensible la obligación de la información sobre alérgenos en los alimentos no envasados (comercio minorista y restauración). Algunos de los principales cambios producidos en el etiquetado son:\n\n- La información obligatoria se indicará en un lugar destacado.\n- Mejora la legibilidad: tamaño de letra de al menos 1,2 mm.\n- Las sustancias que causan alergias se destacan en la lista de ingredientes con un tamaño mínimo de letra que las diferencie del resto de ingredientes.\n- Los alimentos sin envasar también deben informar.\n\nMientras no se disponga de información suficientemente fiable en el etiquetado de los alimentos, los padres y pacientes deben recabar la información necesaria para poder garantizar una alimentación variada y equilibrada sin el riesgo de presentar reacciones severas. Además de la información suministrada en la consulta por parte del clínico, las asociaciones de pacientes colaboran actualizando listados de alimentos o aditivos que pueden contener un alergeno determinado y sirviendo de foro para intercambiar información y experiencias (páginas web de interés: www.aepnaa.org y www.alergiainfantillafe.org).\n\nLos pacientes predispuestos a reacciones severas deben ser entrenados para reconocer precozmente los síntomas de una reacción alérgica a un alimento y disponer de dispositivos para administrarse adrenalina en caso de su ingesta accidental⁴⁰.\n\n### 8\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}